De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer

被引：0
|
作者：
Lorena Gonzalez
Joanne Mortimer
Laura Kruper
机构：
[1] City of Hope National Medical Center,Department of Surgery, Division of Breast Surgery
[2] City of Hope National Medical Center,Department of Medical Oncology
来源：
Current Breast Cancer Reports | 2021年 / 13卷
关键词：
Systemic chemotherapy; Her2+ breast cancer; Triple-negative breast cancer; T1a,bN0;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：151 / 156
页数：5
相关论文
共 50 条
  • [41] The evolution in management of patients with subcentimeter, node-negative, triple-negative breast cancer Discussion
    Edney, James
    Wolfe, Emily
    Mangram, Alicia
    Chagpar, Anees
    AMERICAN JOURNAL OF SURGERY, 2013, 206 (06): : 892 - 893
  • [42] High recurrence risk in pT1bc HER2-positive, triple-negative, node-negative early breast cancer patients
    Vaccaro, A.
    Ciancola, F.
    Pizzuti, L.
    Sperduti, I.
    Moscetti, L.
    Vici, P.
    Longo, F.
    Ruggeri, E.
    Di Seri, M.
    Giampaolo, M. A.
    Gamucci, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Distribution of PD-L1, TROP2 and HER2- “lowness” in early triple-negative breast cancer: an opportunity for treatment de-escalation
    Maria Jose Bueno
    Silvana Mouron
    Eduardo Caleiras
    Mario Martínez
    Luis Manso
    Ramón Colomer
    Miguel Quintela-Fandino
    Clinical and Translational Oncology, 2024, 26 : 1273 - 1279
  • [44] Distribution of PD-L1, TROP2 and HER2-"lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation
    Bueno, Maria Jose
    Mouron, Silvana
    Caleiras, Eduardo
    Martinez, Mario
    Manso, Luis
    Colomer, Ramon
    Quintela-Fandino, Miguel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (05): : 1273 - 1279
  • [45] Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer
    Hao, Xiaopeng
    Gao, Xianqi
    Yin, Shanshan
    Jiang, Zefei
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [46] Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies
    Abuhadra, Nour
    Stecklein, Shane
    Sharma, Priyanka
    Moulder, Stacy
    ONCOLOGIST, 2022, 27 (01): : 30 - 39
  • [47] The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer
    Duan, Fangfang
    Zhong, Muyi
    Ye, Jinhui
    Wang, Li
    Jiang, Chang
    Yuan, Zhongyu
    Bi, Xiwen
    Huang, Jiajia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [48] Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer
    Yu, Zhigang
    TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
  • [49] MUC1 expression in early-stage triple-negative breast cancer
    Miedler, J.
    Abdul-Karim, F.
    Wang, N.
    Baar, J.
    CANCER RESEARCH, 2009, 69 (02) : 207S - 207S
  • [50] Progress in systemic therapy for triple-negative breast cancer
    Hongnan Mo
    Binghe Xu
    Frontiers of Medicine, 2021, 15 (01) : 1 - 10
12345